Advocacy intelligence hub — real-time data for patient organizations
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Gamimune N
(Immune globulin intravenous, human)Orphan drugstandardBayer Corporation
Human Immunoglobulin G [EPC]
12.1 Mechanism of Action BIVIGAM is a replacement therapy in patients with primary humoral immunodeficiency (PI) (e.g. agammaglobulinaemia, hypogammag...
Eyal Grunebaum, MD
The Hospital for Sick Children
Stephen Jolles, MD
University Hospital of Wales, Cardiff, UK
Richard L Wasserman, MD, MD, PhD
📍 DALLAS, TX
Michael Borte, MD
Klinik für Kinder-und Jugendmedizin am Städtischen Klinikum St. Georg, Leipzig, Germany
Isaac R Melamed, MD, M.D
1st Allergey and Clinical Research Center
📍 CENTENNIAL, CO
Eric Wolford, PT
Bio Products Laboratory
📍 CHARLESTON, SC